Respiratory Syncytial Virus Incidence in Young Children in the United States: Impact of Methodologies and Patient Characteristics

Documenti analoghi

• Economic Burden of Medically Attended Respiratory Syncytial Virus Infections Among Privately Insured Children Under 5 Years of Age in the USA
  di: Phuong T. Tran, et al.
  Pubblicazione: (2024)
• Host Immune Response to Respiratory Syncytial Virus Infection in Children
  di: Gang Chen, et al.
  Pubblicazione: (2025)
• Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019
  di: Caihua Liang, et al.
  Pubblicazione: (2025)
• Impact of COVID‐19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children
  di: Yingfeng Lu, et al.
  Pubblicazione: (2024)
• Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Australia Between 2010 and 2019
  di: Zirke Wiid, et al.
  Pubblicazione: (2025)